Skip to main content
NUTX logo

NUTX · Nutex Health Inc. · Executive Compensation

Track NUTX — free
$162.64 +0.54 (+0.33%) At close · Nov 20 Q1 2026 earnings call transcript
Market Cap
$1.12B
Shares
6.86M
Volume · Nov 20 157.56K Avg daily vol (3M) 149.54K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Wesley Bamburg Appointed 2025-09-22
Michael L. Reed Appointed 2025-09-04
Joshua DeTillio
“Mr. DeTillio’s decision to resign is not the result of any dispute or disagreement with the Company, the Company's management or the Board of Directors of the Company on any matter relating to the Company's operations, policies or practices.”
Resigned 2025-07-11
Scott J. Saunders Appointed 2024-04-08
Dr. Kelvin Spears Appointed 2024-02-29
Joshua DeTillio Appointed 2023-09-05
Mitchel Creem Appointed 2023-07-05
Michael L. Reed Appointed 2023-07-05
Cheryl Grenas Appointed 2023-07-05
John Waters Appointed 2023-07-05
Danniel Stites Appointed 2023-07-05
Warren Hosseinion Appointed 2023-07-05
Thomas T. Vo Appointed 2023-07-05
Dr. Danniel Stites Appointed 2023-04-05
Jon Bates Appointed 2022-06-10
Matt S. Young, M.D. Appointed 2022-04-04
Michael Reed Appointed 2022-04-04
Cheryl Grenas, R.N., MSN Appointed 2022-04-04
Mitch Creem Appointed 2022-04-04
John Waters, CPA Appointed 2022-04-04
Pamela Montgomery, J.D., LL.M, MSN, BSN, R.N. Appointed 2022-04-04
Elisa Luqman, J.D., MBA Appointed 2022-04-04
Larry Schimmel, M.D. Appointed 2022-04-04
Michael Chang, M.D. Appointed 2022-04-04
Denise Pufal Appointed 2022-04-04

Leadership

Key facts CIK 1479681 CUSIP 67079U306 13F (30d) 181 filings 167 filers Visit website Investor relations